DRUG DEVELOPMENT
Drug Development
Oracle Launches Life Sciences AI Platform With 129M Patient Records
Oracle unveils AI-powered data platform combining 129M+ de-identified health records with agentic AI for pharmaceutical research and drug development.
Drug Development
AI Model TxGNN Utilizes Zero-Shot Learning to Repurpose Drugs for Rare Diseases
Harvard scientists develop TxGNN, an AI model using zero-shot learning to identify new uses for existing drugs, potentially closing treatment gaps for rare diseases.
